MedTrace Logo

Cross-cultural Adaptation and Validation of Arabic Version of COMI in Patients With Chronic Neck Pain

NCT04136964 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-07-28

No results posted yet for this study

Summary

PURPOSE:

To translate, validate and examine the psychometric properties of the Arabic version of the COMI in Egyptian patients with neck pain.

BACKGROUND:

Neck pain is a highly prevalent musculoskeletal disorders in adults affecting from 45.5% to 48%. It may cause disability that interferes with the quality of life. It is usually treated conservatively. To evaluate treatment effectiveness, patients need close monitoring and follow-up.

Different assessment tools are recommended including patient reported outcome measures. One of the newly introduced outcome measure is The Neck Core Outcome Measure Index (COMI). It is characterized by being brief, simple, self-reported and easy to answer questionnaire. The SPINE TANGO, which is the spine organization In Europe, has recommended its use for all patients with spine disorders.

This questionnaire has been translated into different languages such as German, Polish and Italian but it has never been translated and validated in the Arabic language.

HYPOTHESES

1. The Arabic version of neck-COMI will be a valid tool for the assessment of neck pain in Egyptian patients.
2. The Arabic version of neck-COMI will be a reliable tool for the assessment of neck pain in Egyptian patients.

RESEARCH QUESTION:

Will the Arabic version of neck-COMI be a valid and reliable tool to assess neck pain in the Egyptian patients?

Conditions

  • Chronic Neck Pain

Interventions

OTHER

Neck COMI

Patients will be asked to fill a questionnaire booklet consisting of five patient-reported outcome measures twice within 14 days.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Aliaa Regan Youssef, PhD · Cairo University

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2021-12-30
Completion
2022-03-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04136964 on ClinicalTrials.gov